in a prospective randomized safety and efficacy trial , febrile cancer patients received either ticarcillin disodium combined with the beta-lactamase inhibitor clavulante potassium ( timentin , beecham laboratories , bristol , tn ) plus moxalactam ( t+m ) , or piperacillin plus moxalactam ( p+m ) as initial empiric antimicrobial therapy .
C0546880
ticarcillin
C0076686
timentin